Global Cardiac Surgery Devices Market Size By Type (Perfusion Disposables, Catheters), By Application (Hospitals, Ambulatory Surgical Centres), By Region, And Segment Forecasts, 2023 to 2032

lobal Cardiac Surgery Devices Market Report Description

The Global Cardiac Surgery Devices Market was valued at USD 3.6 billion in 2023 and is projected to surpass USD 6.4 billion by 2031, growing at a CAGR of 7.4% during the forecast period from 2023 to 2031. The market is experiencing robust growth driven by the increasing prevalence of cardiovascular diseases (CVDs), the rising aging population, and technological advancements in surgical devices. Cardiac surgery devices, including heart-lung machines, defibrillators, catheters, and valves, are critical in supporting and enhancing outcomes during complex cardiac procedures. The demand is further propelled by a global shift toward minimally invasive and robot-assisted surgeries, offering enhanced precision and quicker patient recovery.

Drivers:

1. Rising Prevalence of Cardiovascular Diseases (CVDs):

The increasing incidence of heart-related conditions, including coronary artery disease and heart failure, is a major driver of demand for advanced cardiac surgical interventions. According to the World Health Organization, CVDs remain the leading cause of mortality globally.

2. Growth in the Geriatric Population:

Aging is closely associated with increased cardiovascular risks. As the global elderly population grows, the need for cardiac interventions and associated surgical devices also rises significantly.

3. Technological Innovations in Surgical Devices:

Advancements such as minimally invasive cardiac surgery (MICS), robotic-assisted procedures, and smart cardiac devices are enhancing surgical efficiency and reducing procedural risks, fostering greater adoption across hospitals and surgical centers.

Restraints:

1. High Cost of Cardiac Surgery Procedures and Devices:

Despite their effectiveness, cardiac surgical procedures and the associated devices come with high costs, limiting access in low- and middle-income countries.

2. Risk of Complications and Device Failures:

While generally safe, cardiac surgeries carry risks including infections, bleeding, and device malfunction, which can act as deterrents for both patients and healthcare providers.

Opportunity:

1. Expanding Healthcare Infrastructure in Emerging Markets:

Countries in Asia-Pacific and Latin America are witnessing rapid improvements in healthcare facilities and access to specialized surgical care, presenting significant opportunities for market players.

2. Rising Preference for Minimally Invasive Surgeries:

With reduced trauma, shorter hospital stays, and faster recovery times, minimally invasive cardiac procedures are becoming increasingly preferred, boosting the demand for next-generation surgical tools and devices.

Market by System Type Insights:

Based on system type, the Heart-Lung Machines segment held the largest market share in 2023. These machines are essential in open-heart surgeries, allowing for cardiopulmonary bypass and ensuring a bloodless, motionless surgical field. Meanwhile, the Minimally Invasive Cardiac Surgery Devices segment is projected to grow at the fastest pace due to advancements in imaging and surgical navigation technologies.

Market by End-use Insights:

In terms of end use, Hospitals & Cardiac Centers emerged as the largest end-user segment in 2023, driven by the availability of skilled professionals and high patient footfall for cardiac surgeries. The Ambulatory Surgical Centers segment is gaining traction as more facilities adopt minimally invasive devices and techniques that allow for shorter procedural times and quicker discharges.

Market by Regional Insights:

North America dominated the global cardiac surgery devices market in 2023, supported by a high prevalence of heart disease, strong healthcare infrastructure, and rapid adoption of innovative technologies. However, Asia-Pacific is projected to register the highest CAGR during the forecast period due to rising awareness, increasing healthcare investments, and an expanding patient pool.

Competitive Scenario:

Key players in the global cardiac surgery devices market include:

Medtronic plc

Abbott Laboratories

Boston Scientific Corporation

LivaNova PLC

Getinge AB

Edwards Lifesciences Corporation

Terumo Corporation

B. Braun Melsungen AG

These companies are focusing on R&D, strategic collaborations, and product innovations. For instance:

In 2023, Medtronic launched an upgraded heart-lung machine with enhanced monitoring capabilities.

Abbott announced regulatory approval in 2024 for its minimally invasive mitral valve repair system.

LivaNova introduced a next-gen perfusion system with AI-driven decision support tools in 2025.

Scope of Work – Global Cardiac Surgery Devices Market

Report Metric Details

Market Size (2023) USD 3.6 billion

Projected Market Si